Johnson & Johnson (NYSE:JNJ) dropped by -0.66 or -0.78 points during the last session to $115.87 per share. One of the highlights of the day was the net money flow figure, which stood at $229.95 million even as the stock accepted $318.01 million in upticks but rejected $88.06 million in downticks. The up/down ratio for the last observation was a 3.61. The 1-week percentage change for the stock price is registered at -0.98%.A block transaction occurred with $239.15 million in upticks and $1.19 million in downticks while the up/down ratio was calculated to be 200.89. The stock witnessed a net inflow of $237.96 million at the end of the block trade.
Johnson & Johnson has dropped 1.31% in the last five trading days, however, the shares have posted positive gains of 2.39% in the last 4 weeks. Johnson & Johnson is up 8.19% in the last 3-month period. Year-to-Date the stock performance stands at 14.05%.
Currently the company Insiders own 0.11% of Johnson & Johnson shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by -18.24% . Institutional Investors own 67.95% of Johnson & Johnson shares. During last six month period, the net percent change held by insiders has seen a change of -18.24%. . On the companys insider trading activities, Pruden Gary J, officer (Exec VP, WW Chair, Med Devices) of Johnson & Johnson, unloaded 9,735 shares at an average price of $116.03 on June 7, 2016. The total amount of the transaction was worth $1,129,552, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.
Johnson & Johnson (NYSE:JNJ) witnessed a decline in the market cap on Friday as its shares dropped 0.99% or 1.16 points. After the session commenced at $116.62, the stock reached the higher end at $116.67 while it hit a low of $115.01. With the volume soaring to 10,702,199 shares, the last trade was called at $115.48. The company has a 52-week high of $117.74. The company has a market cap of $317,644 million and there are 2,750,644,300 shares in outstanding. The 52-week low of the share price is $81.79.
Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a range of products in the health care field. The Company has more than 265 operating companies conducting business around the world. The Companys primary focus is products related to human health and well-being. The Company is organized into three business segments: Consumer, Pharmaceutical and Medical Devices. The Companys subsidiaries operate 134 manufacturing facilities occupying approximately 21.5 million square feet of floor space. The Companys research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.